CMC Biologics Inc., a commercial manufacturer of therapeutic proteins with operations in Copenhagen, Denmark; Seattle, WA; and Berkeley, CA, has named Gustavo Mahler as its chief executive officer, effective January 1, 2016. The company has 500 employees globally, and offers fully integrated, biopharmaceutical process development and manufacturing services for clinical and commercially launched biological medicines. Mr. Mahler has more that 20 years of executive management experience in biolo...